Omada Health Inc(OMDA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 311.55 | EPS (ttm) | 0.07 | Insider Own | 50.84% | Shs Outstand | 60.6M | Perf Week | -9.97% |
| Market Cap | 1.25B | Forward P/E | 45.94 | EPS next Y | 35.82% | Insider Trans | -0.96% | Shs Float | 30.1M | Perf Month | -15.88% |
| Enterprise Value | 1.03B | PEG | - | EPS next Q | 0.07 | Inst Own | 71.13% | Short Float | 19.07% | Perf Quarter | 19.6% |
| Income | 0.00B | P/S | 4.05 | EPS this Y | 193.88% | Inst Trans | 13.23% | Short Ratio | 4.42 | Perf Half Y | 41.09% |
| Sales | 0.31B | P/B | 4.92 | EPS next 5Y | - | ROA | 1.36% | Short Interest | 5.74M | Perf YTD | 29.91% |
| Book/sh | 4.17 | P/C | 5.66 | EPS past 3/5Y | 44.81% - | ROE | 1.84% | 52W High | -23.83% ($26.92) | Perf Year | -6.65% |
| Cash/sh | 3.62 | P/FCF | 55.21 | Sales past 3/5Y | 42.89% - | ROIC | 1.7% | 52W Low | 99.42% ($10.28) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 190.28 | EPS Y/Y TTM | 112.46% | Gross Margin | 68.08% | Volatility(W/M) | 6.22% 4.68% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 3.34 | Sales Y/Y TTM | 47.63% | Oper. Margin | -0.15% | ATR (14) | 1.24 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.8 | EPS Q/Q | 189.42% | Profit Margin | 1.39% | RSI (14) | 39.25 | Recom | 1.42 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.85 | Sales Q/Q | 43.12% | SMA20 | -10.99% ($23.03) | Beta | 2.07 | Target Price | $28.42 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/8/6 | SMA50 | -9.23% ($22.58) | Rel Volume | 0.73 | Prev Close | $19.66 |
| Employees | 916 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 165.59% 9.74% | SMA200 | 20.26% ($17.05) | Avg Volume(3M) | 1.30M | Price | $20.5 |
| IPO | 2025/6/6 | Option/Short | Yes/Yes | Trades | 14345 | Volume | 951,503 | Change | 4.27% |
Company
OMDA is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 Omada Health (OMDA) is a US-based virtual care platform company that specializes in managing chronic conditions such as diabetes and hypertension. By combining virtual coaching, connected devices, and behavior change programs, it provides remote care for prediabetes, diabetes, hypertension, and musculoskeletal conditions, and has established itself as a leading provider of the Centers for Disease Control and Prevention (CDC)-recognized diabetes prevention program. Its business model is primarily enterprise-focused, serving employers, health insurance plans, and healthcare systems as customers.
Over the past 1 year, roughly in the middle
24% below its 1-year high.
OMDA has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +193.9% this year.
Tap to view numbers
The price looks about right
Trading at 311.6 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 71.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $1B.
FAQ
What kind of company is OMDA?
OMDA belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of OMDA?
The market cap of OMDA is approximately $1.3B, ranking 2,456 within its sector.
What is the P/E ratio of OMDA?
OMDA has a P/E ratio of approximately 311.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for OMDA?
OMDA has recorded a 52-week high of $26.92 and a low of $10.28.